NCT07101315

Brief Summary

The goal of this clinical trial is to learn if performing gallbladder surgery early is as safe and effective as delaying it for people with acute cholecystitis (a sudden gallbladder infection). The main questions it aims to answer are:

  • Do participants who have early surgery have a similar rate of complications compared to those who have delayed surgery?
  • How does the timing of surgery affect the length of the hospital stay? Researchers will compare two groups:
  • An early surgery group
  • A delayed surgery group

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 27, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

July 27, 2025

Last Update Submit

July 27, 2025

Conditions

Keywords

Laparoscopic CholecystectomyGallstonesBiliary DiseaseSurgical Timing

Outcome Measures

Primary Outcomes (3)

  • Overall Postoperative Complications

    Incidence of any postoperative complication within 30 days

    Within 30 days post-surgery

  • Conversion to Open Surgery

    Rate of conversion from laparoscopic to open cholecystectomy during the procedure.

    Intraoperative

  • Operative Time

    Duration of surgery, measured in minutes from skin incision to skin closure.

    Intraoperative

Secondary Outcomes (4)

  • Postoperative Length of Hospital Stay

    Up to 30 days post-surgery

  • Duration of Postoperative Pain

    Up to 30 days post-surgery

  • Time to Return to Normal Daily Activities

    Up to 30 days post-surgery

  • 30-Day Readmission Rate

    30 days

Study Arms (2)

Early Laparoscopic Cholecystectomy (ELC)

EXPERIMENTAL

Participants underwent laparoscopic cholecystectomy within 72 hours of symptom onset during the index hospital admission.

Procedure: Laparoscopic Cholecystectomy

Delayed Laparoscopic Cholecystectomy (DLC)

ACTIVE COMPARATOR

Participants received initial non-operative management with antibiotics and analgesics, followed by elective laparoscopic cholecystectomy 6-8 weeks later.

Procedure: Laparoscopic Cholecystectomy

Interventions

Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.

Delayed Laparoscopic Cholecystectomy (DLC)Early Laparoscopic Cholecystectomy (ELC)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Yemeni nationals aged 18-70 years
  • A clinical diagnosis of acute cholecystitis confirmed by clinical presentation, laboratory findings, and imaging studies
  • Symptom duration of less than 72 hours at presentation
  • Fitness for general anesthesia (American Society of Anesthesiologists \[ASA\] physical status classification I-III)
  • Provision of written informed consent

You may not qualify if:

  • Evidence of choledocholithiasis or acute cholangitis
  • Severe comorbidities precluding surgery (ASA class IV-V)
  • Coagulopathy (INR \>1.5 or platelet count \<100,000/μL)
  • Pregnancy
  • Previous major upper abdominal surgery
  • Patient refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Al-Kuwait University Hospital

Sanaa, Yemen

Location

Al-Thawra Modern General Hospital

Sanaa, Yemen

Location

MeSH Terms

Conditions

Cholecystitis, AcuteGallstonesGallbladder Diseases

Interventions

Cholecystectomy, Laparoscopic

Condition Hierarchy (Ancestors)

CholecystitisBiliary Tract DiseasesDigestive System DiseasesCholelithiasisCholecystolithiasisCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Study Officials

  • Mohammed A Issa, Professor

    Sana'a University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 27, 2025

First Posted

August 3, 2025

Study Start

January 1, 2022

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

August 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that underlie the results reported in this article, after publication. This includes data for all primary and secondary outcome measures. The study protocol will not be shared.

Time Frame
Data will be available beginning 3 months after article publication and the access period will remain open for 5 years.
Access Criteria
Data will be made available to qualified researchers for meta-analysis or other secondary analyses consistent with the original aims of the study. Researchers must submit a methodologically sound proposal to the corresponding author at h.jowah@su.edu.ye. A signed data access agreement will be required prior to the release of any data.

Locations